In Brief: Summit Technology
This article was originally published in The Gray Sheet
Executive Summary
Summit Technology: Premarket approval application supplement for use of the company's Apex Plus excimer laser system in correcting myopic astigmatism was submitted to FDA on April 2, the company says in an April 25 release. Summit received FDA approval in February to market the Apex Plus system in the U.S. for photorefractive keratectomy and phototherapeutic keratectomy, the same indications as the SVS Apex system ("The Gray Sheet" Feb. 24, In Brief). The Plus system incorporates software and hardware modifications that allow use of an erodible laser disk to perform astigmatism correction...